Fetal DNA oxidation and repair in neurodegeneration
神经退行性疾病中胎儿 DNA 氧化和修复
基本信息
- 批准号:7229998
- 负责人:
- 金额:$ 13.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-01-01 至 2008-12-31
- 项目状态:已结题
- 来源:
- 关键词:8-Oxo-2&apos-Deoxyguanosine8-hydroxyguanosine8-oxoguanineBrainCockayne SyndromeDNADNA RepairDNA lesionDefectDetectionDevelopmentDoseEngineeringEnzymesExcisionExposure toFetal DevelopmentFetusGene ExpressionGene Expression Microarray AnalysisGene TargetingGenesGenetic TranscriptionHigh Pressure Liquid ChromatographyHumanIngestionKnock-outKnockout MiceLigandsMediatingMethylmercury CompoundsModelingMusMutationNerve DegenerationNeuraxisNeurodevelopmental DeficitPathologicPathologyPathway interactionsPatternPerinatal ExposurePolymerase Chain ReactionPredispositionProteinsReactive Oxygen SpeciesRegulator GenesRegulatory ElementRiskRisk FactorsRoleSeafoodTestingToxic Environmental SubstancesToxic effectTranscription-Coupled RepairTransgenic Micebasebehavior testcatalaseenvironmental agentenvironmental chemicalfetalin uteroin vivoinsightmouse modeloxidationoxidative DNA damagepostnatalprenatalrepaired
项目摘要
DESCRIPTION (provided by applicant): Methylmercury (MeHg) is an environmental agent introduced to humans primarily via the ingestion of contaminated seafood. Prenatal MeHg exposure induces neurodevelopmental deficits, at doses below those causing systemic toxicity. One potential toxicological mechanism for this and other environmental chemicals likely involves reactive oxygen species (ROS) formation, as the fetus has low antioxidative protection. This toxicity may involve oxidative DNA lesions, the most prominent of which is 8-oxoguanine (8-oxoG), which can result in mutations or altered gene transcription. The latter is potentially relevant to developmental pathologies. Repair of 8-oxoG is carried out by the base excision (BER) and transcription-coupled (TCR) repair pathways. We hypothesize that ROS-mediated oxidative DNA damage in fetal brain modifies specific gene expression levels, contributing to postnatal neurodevelopmental deficits. The progeny of mouse models with genetic alterations in 8-oxoG repair activity will be assessed for neurodevelopmental deficits after in utero exposure to MeHg. Oxoguanine glycosylase 1 (ogg1) knockout (BER-deficient) and Cockayne syndrome B (CSB) knockout (TCR-deficient) mice will be tested as repair-deficient models, while transgenic mice expressing highly active bacterial formamidopyrimidine glycosylase (Fpg) will be genetically engineered and employed as a BER-enhanced model. Fetal ROS and 8-oxoG, specific gene regulatory targets for oxidation and associated gene expression changes in utero will be analyzed in the same fetal brains, and assessed with respect to postnatal CMS pathologies in the progeny. 8-OxoG will be quantified by HPLC with electrochemical detection, oxidation of target gene regulatory elements will be characterized by ligand- mediated PCR, gene expression by microarray analysis, and neurodevelopmental deficits by behavioral tests. These studies will provide mechanistic insight into the fetal origin of environmentally-induced neurodevelopmental defects, and the role of DNA repair activity as a risk factor.
描述(由申请人提供):甲基汞 (MeHg) 是一种环境因子,主要通过摄入受污染的海鲜而引入人类。产前接触甲基汞会导致神经发育缺陷,剂量低于引起全身毒性的剂量。这种化学物质和其他环境化学物质的一种潜在毒理学机制可能涉及活性氧(ROS)的形成,因为胎儿的抗氧化保护能力较低。这种毒性可能涉及 DNA 氧化损伤,其中最突出的是 8-氧代鸟嘌呤 (8-oxoG),它可能导致突变或基因转录改变。后者可能与发育病理学相关。 8-oxoG 的修复是通过碱基切除 (BER) 和转录偶联 (TCR) 修复途径进行的。我们假设胎儿大脑中 ROS 介导的氧化 DNA 损伤会改变特定的基因表达水平,从而导致出生后神经发育缺陷。 8-oxoG 修复活性基因改变的小鼠模型的后代将在子宫内暴露于甲基汞后评估神经发育缺陷。氧鸟嘌呤糖基化酶 1 (ogg1) 敲除(BER 缺陷)和科凯恩综合征 B (CSB) 敲除(TCR 缺陷)小鼠将作为修复缺陷模型进行测试,而表达高活性细菌甲酰胺嘧啶糖基化酶 (Fpg) 的转基因小鼠将经过基因工程改造并用作 BER 增强模型。胎儿 ROS 和 8-oxoG、子宫内氧化的特定基因调控靶点和相关基因表达变化将在同一胎儿大脑中进行分析,并根据后代的出生后 CMS 病理进行评估。 8-OxoG 将通过 HPLC 和电化学检测进行定量,靶基因调控元件的氧化将通过配体介导的 PCR 进行表征,基因表达通过微阵列分析进行表征,神经发育缺陷通过行为测试进行表征。这些研究将为环境引起的神经发育缺陷的胎儿起源以及 DNA 修复活性作为危险因素的作用提供机制上的见解。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Expression of human oxoguanine glycosylase 1 or formamidopyrimidine glycosylase in human embryonic kidney 293 cells exacerbates methylmercury toxicity in vitro.
- DOI:10.1016/j.taap.2013.04.008
- 发表时间:2013-08
- 期刊:
- 影响因子:3.8
- 作者:S. L. Ondovcik;T. J. Preston;G. McCallum;P. G. Wells
- 通讯作者:S. L. Ondovcik;T. J. Preston;G. McCallum;P. G. Wells
Base excision repair of reactive oxygen species-initiated 7,8-dihydro-8-oxo-2'-deoxyguanosine inhibits the cytotoxicity of platinum anticancer drugs.
- DOI:10.1158/1535-7163.mct-08-0929
- 发表时间:2009-07
- 期刊:
- 影响因子:5.7
- 作者:Preston TJ;Henderson JT;McCallum GP;Wells PG
- 通讯作者:Wells PG
Receptor- and reactive intermediate-mediated mechanisms of teratogenesis.
受体和反应中间体介导的致畸机制。
- DOI:10.1007/978-3-642-00663-0_6
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Wells,PeterG;Lee,CrystalJJ;McCallum,GordonP;Perstin,Julia;Harper,PatriciaA
- 通讯作者:Harper,PatriciaA
Oxidative DNA damage and repair in teratogenesis and neurodevelopmental deficits.
- DOI:10.1002/bdrc.20177
- 发表时间:2010-06
- 期刊:
- 影响因子:0
- 作者:P. G. Wells;G. McCallum;Kyla Lam;J. Henderson;S. L. Ondovcik
- 通讯作者:P. G. Wells;G. McCallum;Kyla Lam;J. Henderson;S. L. Ondovcik
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER G WELLS其他文献
PETER G WELLS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER G WELLS', 18)}}的其他基金
Fetal DNA oxidation and repair in neurodegeneration
神经退行性疾病中胎儿 DNA 氧化和修复
- 批准号:
7038483 - 财政年份:2006
- 资助金额:
$ 13.11万 - 项目类别:
相似海外基金
6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
GBM 中的 6-硫代-2-脱氧鸟苷:药效学评估、先前护理标准的影响和人类 0 期研究
- 批准号:
10305569 - 财政年份:2021
- 资助金额:
$ 13.11万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
GBM 中的 6-硫代-2-脱氧鸟苷:药效学评估、先前护理标准的影响和人类 0 期研究
- 批准号:
10488244 - 财政年份:2021
- 资助金额:
$ 13.11万 - 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
- 批准号:
10305565 - 财政年份:2021
- 资助金额:
$ 13.11万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
- 批准号:
10488242 - 财政年份:2021
- 资助金额:
$ 13.11万 - 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
- 批准号:
10488237 - 财政年份:2021
- 资助金额:
$ 13.11万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
- 批准号:
10305568 - 财政年份:2021
- 资助金额:
$ 13.11万 - 项目类别:
RUI: Chemical Investigations into the Bioactivity of the DNA Lesion 8-Oxo-2'-deoxyguanosine
RUI:DNA 损伤 8-Oxo-2-脱氧鸟苷生物活性的化学研究
- 批准号:
1903855 - 财政年份:2019
- 资助金额:
$ 13.11万 - 项目类别:
Standard Grant
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
- 批准号:
311600-2013 - 财政年份:2017
- 资助金额:
$ 13.11万 - 项目类别:
Discovery Grants Program - Individual
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
- 批准号:
311600-2013 - 财政年份:2015
- 资助金额:
$ 13.11万 - 项目类别:
Discovery Grants Program - Individual
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
- 批准号:
311600-2013 - 财政年份:2014
- 资助金额:
$ 13.11万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




